Agency Forms Undergoing Paperwork Reduction Act Review, 68066-68067 [E9-30339]

Download as PDF 68066 Federal Register / Vol. 74, No. 244 / Tuesday, December 22, 2009 / Notices TABLE—ESTIMATES OF ANNUAL BURDEN Number of respondents Frequency of response Type of respondents Form Investigators and Designee ............... Statement of Investigator ................... 17,128 1 Supplemental Investigator ................. 17,128 1 Financial Disclosure ........................... 17,128 1 ............................................................ 17,128 ........................ srobinson on DSKHWCL6B1PROD with NOTICES Totals .......................................... There are no capital costs, operating costs, or maintenance costs. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information; including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Attention: NIH Desk Officer, Office of Management and Budget, at OIRA_submission@omb.eop.gov. or by fax to 202–395–6974. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Charles L. Hall, Jr., Chief, Pharmaceutical Management Branch, Cancer Therapy Evaluation Program, Division of the Cancer Treatment and Diagnosis, and Centers, National Cancer Institute, Executive Plaza North, Room 7148, 9000 Rockville Pike, Bethesda, MD 20892 or call non-toll-free number 301–496–5725 or E-mail your request, including your address, to: Hallch@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days following the date of this publication. VerDate Nov<24>2008 18:01 Dec 21, 2009 Jkt 220001 Dated: December 15, 2009. Kristine Miller, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. E9–30390 Filed 12–21–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–10–0600] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Model Performance Evaluation Program for Mycobacterium tuberculosis and Non-tuberculous Mycobacterium Drug Susceptibility Testing (OMB Control No. 0920–0600, expiration date 03/31/2010)— Revision—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Centers for Disease Control and Prevention (CDC). Background and Brief Description As part of the continuing effort to support both domestic and global public health objectives for treatment of tuberculosis (TB), prevention of multidrug resistance, and surveillance programs, CDC is requesting approval PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Average time per response Total hour burden 0.25 (15 minutes). 0.167 (10 minutes). 0.083 (5 minutes). 4,282 ..................... 8,564 2,855 1,427 from the Office of Management and Budget to revise a currently approved data collection, the Model Performance Evaluation Program for Mycobacterium tuberculosis and Non-tuberculous Mycobacterium Drug Susceptibility Testing. This request includes changes to the Results Form and re-introduction of the Laboratory Practices Questionnaire. While the overall number of cases of TB in the U.S. has decreased, rates still remain high among foreign-born persons, prisoners, homeless populations, and individuals infected with HIV in major metropolitan areas. The rate of TB cases detected in foreignborn persons has been reported to be more than nine times higher than the rate among the U.S. born population. CDC’s goal to eliminate TB will be virtually impossible without considerable effort in assisting heavy disease burden countries in the reduction of tuberculosis. The Model Performance Evaluation Program for Mycobacterium tuberculosis and Nontuberculous Mycobacterium Drug Susceptibility Testing program supports this role by monitoring and evaluating the level of performance and practices among national and international laboratories performing M. tuberculosis susceptibility testing. Participation in this program is one way laboratories can ensure high-quality laboratory testing, resulting in accurate and reliable testing results. By providing an evaluation program to assess the ability of the laboratories to test for drug resistant M. tuberculosis and selected strains of Non-tuberculous Mycobacteria (NTM), laboratories also have a self-assessment tool to aid in optimizing their skills in susceptibility testing. The information obtained from laboratories on susceptibility testing practices and procedures is used to establish variables related to good performance, assessing training needs, and aid with the development of practice standards. Participants in this program include clinical and public health laboratories. E:\FR\FM\22DEN1.SGM 22DEN1 68067 Federal Register / Vol. 74, No. 244 / Tuesday, December 22, 2009 / Notices Participants register by submitting an Enrollment Form. Data collection from domestic laboratory participants occurs twice per year. The data collected in this program will include the susceptibility test results of primary and secondary drugs, drug concentrations, and test methods performed by laboratories on a set of performance since responses are received every other year. Participants may submit changes about their laboratory using the Laboratory Information Change Form. There is no cost to respondents to participate other than their time. The total annualized burden for this information collection request is 166 hours. evaluation (PE) samples. The PE samples are sent to participants twice a year. Participants also report demographic data such as laboratory type and the number of tests performed annually. Participants report this data every two years. The burden for the Laboratory Practices Questionnaire has been adjusted for the average per year, ESTIMATE OF ANNUALIZED BURDEN HOURS Form Respondents Enrollment form ....................................................................... Laboratory Change form ......................................................... Susceptibility Testing Results Form ........................................ Laboratory Practices Questionnaire ........................................ Dated: December 14, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–30339 Filed 12–21–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Application for the Emergency Form for CSBG/ARRA Expenditure Report. OMB No.: 0970–0369. Description: On February 17 2009, President Obama signed into law the Labs Labs Labs Labs Number of respondents ....................................... ....................................... ....................................... ....................................... American Recovery and Reinvestment Act of 2009 (Recovery Act). The Recovery Act provided for $1 billion in additional funds to the Community Services Block Grant (CSBG) program for Federal Fiscal Year 2009; however the grant period runs through FY 2010. As with regularly appropriated CSBG funds, Recovery Act funds may be used for the reduction of poverty, the revitalization of low-income communities, and the empowerment of low-income families and individuals in rural and urban areas to become fully self-sufficient. To be in compliance with Recovery Act (Pub. L. 111–5) Section 1512(c)(1) through (B) a backup sheet was created to identify the various activities that make up the total Federal share of outlays reported on the 269A Report line 10(a). The CSBG/ARRA Fund Number of responses per respondent 4 4 132 66 1 1 2 1 Average burden per response (in hours) 5/60 5/60 30/60 30/60 provides resources to States, Territories, and Tribes to support work and families during this difficult economic period. We plan to issue a backup sheet for the 269A Report with instructions for jurisdictions to complete; which would provide detail information to support line 10(a) of the aforementioned document. Failure to collect this data would compromise ACF’s ability to monitor expenditure patterns by the grantees. Documentation maintenance on financial reporting for the CSBG Fund is governed by 45 CFR 96.30. Respondents: State, Territory, and Tribal agencies administering the Community Service Block Grant(CSBG) Program Fund. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours CSBG/ARRA Plan ........................................................................................... srobinson on DSKHWCL6B1PROD with NOTICES Instrument 103 4 4 1,648 Estimated Total Annual Burden Hours: 1,648 Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: infocollection@acf.hhs.gov. OMB Comment: OMB is required to make a decision concerning the VerDate Nov<24>2008 18:01 Dec 21, 2009 Jkt 220001 collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202–395–7245, Attn: Desk Officer for the Administration for Children and Families. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Dated: December 17, 2009. Robert Sargis, Reports Clearance Officer. [FR Doc. E9–30369 Filed 12–21–09; 8:45 am] BILLING CODE 4184–01–P E:\FR\FM\22DEN1.SGM 22DEN1

Agencies

[Federal Register Volume 74, Number 244 (Tuesday, December 22, 2009)]
[Notices]
[Pages 68066-68067]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30339]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-10-0600]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Model Performance Evaluation Program for Mycobacterium tuberculosis 
and Non-tuberculous Mycobacterium Drug Susceptibility Testing (OMB 
Control No. 0920-0600, expiration date 03/31/2010)--Revision--National 
Center for Preparedness, Detection, and Control of Infectious Diseases 
(NCPDCID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    As part of the continuing effort to support both domestic and 
global public health objectives for treatment of tuberculosis (TB), 
prevention of multi-drug resistance, and surveillance programs, CDC is 
requesting approval from the Office of Management and Budget to revise 
a currently approved data collection, the Model Performance Evaluation 
Program for Mycobacterium tuberculosis and Non-tuberculous 
Mycobacterium Drug Susceptibility Testing. This request includes 
changes to the Results Form and re-introduction of the Laboratory 
Practices Questionnaire.
    While the overall number of cases of TB in the U.S. has decreased, 
rates still remain high among foreign-born persons, prisoners, homeless 
populations, and individuals infected with HIV in major metropolitan 
areas. The rate of TB cases detected in foreign-born persons has been 
reported to be more than nine times higher than the rate among the U.S. 
born population. CDC's goal to eliminate TB will be virtually 
impossible without considerable effort in assisting heavy disease 
burden countries in the reduction of tuberculosis. The Model 
Performance Evaluation Program for Mycobacterium tuberculosis and Non-
tuberculous Mycobacterium Drug Susceptibility Testing program supports 
this role by monitoring and evaluating the level of performance and 
practices among national and international laboratories performing M. 
tuberculosis susceptibility testing. Participation in this program is 
one way laboratories can ensure high-quality laboratory testing, 
resulting in accurate and reliable testing results.
    By providing an evaluation program to assess the ability of the 
laboratories to test for drug resistant M. tuberculosis and selected 
strains of Non-tuberculous Mycobacteria (NTM), laboratories also have a 
self-assessment tool to aid in optimizing their skills in 
susceptibility testing. The information obtained from laboratories on 
susceptibility testing practices and procedures is used to establish 
variables related to good performance, assessing training needs, and 
aid with the development of practice standards.
    Participants in this program include clinical and public health 
laboratories.

[[Page 68067]]

Participants register by submitting an Enrollment Form. Data collection 
from domestic laboratory participants occurs twice per year. The data 
collected in this program will include the susceptibility test results 
of primary and secondary drugs, drug concentrations, and test methods 
performed by laboratories on a set of performance evaluation (PE) 
samples. The PE samples are sent to participants twice a year. 
Participants also report demographic data such as laboratory type and 
the number of tests performed annually. Participants report this data 
every two years. The burden for the Laboratory Practices Questionnaire 
has been adjusted for the average per year, since responses are 
received every other year. Participants may submit changes about their 
laboratory using the Laboratory Information Change Form.
    There is no cost to respondents to participate other than their 
time. The total annualized burden for this information collection 
request is 166 hours.

                                       Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
                 Form                          Respondents           Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Enrollment form.......................  Labs....................               4               1            5/60
Laboratory Change form................  Labs....................               4               1            5/60
Susceptibility Testing Results Form...  Labs....................             132               2           30/60
Laboratory Practices Questionnaire....  Labs....................              66               1           30/60
----------------------------------------------------------------------------------------------------------------


    Dated: December 14, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-30339 Filed 12-21-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.